Delivery Order SPE2DB20D2104-SPE2DB25FMQLD
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic 0.25-0.5 mg/dose pens (3ml) under a firm fixed-price contract. The order, valued at $6,363.37, is scheduled for completion by July 31, 2025, and will be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order was competitively awarded without set-aside designation and represents a single transaction within the company's broader federal pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $3,919.58 to AmerisourceBergen Drug Corp for the supply of Ozempic 0.25-0.5 mg/dose pens (3 mL) on July 24, 2025, with a completion date of July 25, 2025. This competitive award was issued under a firm fixed-price contract type with no set-aside designation. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order...
- The Defense Logistics Agency awarded a $37,417.19 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Ozempic 0.25-0.5 mg/dose pens in 3 mL formulations, with completion targeted for September 15, 2025. This competitively awarded, non-set-aside contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's broader relationship...
- The Defense Logistics Agency awarded a $18,382.70 delivery order to AmerisourceBergen Drug Corp for Ozempic 0.25-0.5 mg/dose pens (3 mL) with a completion date of September 9, 2025. This firm fixed price contract, awarded on September 9, 2025, represents a non-set-aside competitive award for pharmaceutical supply to support federal medical procurement needs. The award was performed from AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $31,326.76 for Ozempic 0.25-0.5 mg/dose pen 3ml pharmaceutical products. This competitively awarded, firm fixed-price delivery order was executed on August 18, 2025, with an ultimate completion date of August 19, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting open competition procurement practices. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $36,233.87 to AmerisourceBergen Drug Corp for the supply of Ozempic 0.25-0.5 mg/dose pens (3ml) on August 22, 2025, with completion scheduled for August 25, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement...
- The Defense Logistics Agency awarded a delivery order valued at $17,024.27 to AmerisourceBergen Drug Corp for the supply of Ozempic 0.25-0.5 mg/dose pens (3ml) on November 3, 2025, with an ultimate completion date of November 4, 2025. This competitive award, issued without set-aside designation, utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is the vendor's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,790.95 on September 18, 2025, for the supply of Ozempic 0.25-0.5 mg/dose pens (3 mL), with completion expected by September 19, 2025. This is a firm fixed price delivery order with no set-aside designation, awarded through competitive procurement. The contract will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order operates under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $27,380.24 to AmerisourceBergen Drug Corp for the supply of Ozempic 0.25-0.5 mg/dose pens in 3ml quantities. This firm fixed-price delivery order was competitively awarded without set-aside designations and carries an ultimate completion date of July 30, 2025. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Ozempic 0.25-0.5 mg/dose pens (3ml) with a ceiling value of $10,555.27. This firm fixed-price delivery order, which is scheduled for completion by November 4, 2025, represents a competitive award with no set-aside designation. The award was fulfilled by AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania, the company's headquarters and primary...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMQLDDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,729.87 for Ozempic 0.25-0.5 mg/dose pens (3 mL) with an ultimate completion date of May 9, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at the contractor's location in Conshohocken, Pennsylvania. The award represents a continuation of pharmaceutical supply support under AmerisourceBergen's broader federal contracting relationship with DLA. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor contract valued at $999,999,999.00 and extending through December 2026. The IDC serves as the enabling vehicle for providing a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including support to the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's extensive contract portfolio with DLA demonstrates the company's established capability as a critical pharmaceutical distributor for federal medical procurement, with consistent delivery of medications across multiple therapeutic domains supporting military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 5/8/25 |